Department of Public Health Sciences, College of Medicine, Penn State University, Hershey, PA 17033, USA.
Department of Medicine, College of Medicine, Penn State University, Hershey, PA 17033, USA.
Int J Environ Res Public Health. 2022 Mar 29;19(7):4034. doi: 10.3390/ijerph19074034.
Continued smoking after a cancer diagnosis is causally associated with increased risks of all-cause and cancer-specific mortality, and of smoking-related second primary cancers. Patient navigation provides individualized assistance to address barriers to smoking cessation treatment and represents a promising bridge to smoking cessation in persons with cancer who smoke cigarettes. We conducted a single-arm interventional cohort study of current smokers identified through prospective health record screening and recruited from Penn State Cancer Institute outpatient clinics. Consented participants received two telephone intervention sessions and gain-framed messaging-based smoking cessation educational materials designed for persons with cancer. The primary study outcome was the feasibility of the patient navigation-based intervention; the secondary outcome was the engagement in smoking cessation treatment at the two-month follow-up. Of 1168 unique screened Cancer Institute patients, 134 (11.5%) were identified as current cigarette smokers. Among 67 patients approached at outpatient clinics, 24 (35.8%) were interested in participating, 12 (17.9%) were enrolled, eight (11.9%) completed the intervention sessions and study assessments, and six engaged in smoking cessation treatment. The participants expressed satisfaction with the intervention sessions (median = 8.5, scale 0-10). The low recruitment rates preclude patient navigation as a feasible method for connecting cancer patients to smoking cessation treatment resources.
癌症诊断后继续吸烟与全因死亡率和癌症特异性死亡率增加以及与吸烟相关的第二原发癌症风险增加有关。患者导航为解决戒烟治疗障碍提供了个性化的帮助，为癌症吸烟者戒烟提供了一个有前途的桥梁。我们对通过前瞻性健康记录筛查并从宾夕法尼亚州立癌症研究所门诊诊所招募的当前吸烟者进行了一项单臂干预性队列研究。同意参与的参与者接受了两次电话干预会议，并获得了基于增益框架的针对癌症患者的戒烟教育材料。主要研究结果是基于患者导航的干预措施的可行性；次要结果是在两个月随访时参与戒烟治疗。在 1168 名独特的癌症研究所筛查患者中，有 134 名（11.5%）被确定为当前吸烟者。在 67 名在门诊就诊的患者中，有 24 名（35.8%）有兴趣参与，有 12 名（17.9%）被录取，有 8 名（11.9%）完成了干预会议和研究评估，有 6 名参与了戒烟治疗。参与者对干预会议表示满意（中位数=8.5，评分 0-10）。低招募率排除了患者导航作为将癌症患者与戒烟治疗资源联系起来的可行方法。
